Semisynthetic p‐Coumaric Acid Derivatives as Lead Dual Inhibitors Against DPP‐IV and GSK‐3β for Antidiabetic Therapy

Documenti analoghi

• Synthesis, Bioactivity and Molecular Modeling Studies on Benzimidazole Derivatives and Its Isosteres as Potent AChE / BChE and GSK3β Inhibitors for Alzheimer's Disease
  di: Gözde Sayar, et al.
  Pubblicazione: (2026)
• Pyrrolidine‐2‐carbonitrile Derivatives as Multifunctional Antidiabetic Agents: Inhibition of α ‐Amylase, α ‐Glucosidase, and DPP‐IV With Structure‐Activity Relationships, HSA Binding, and Molecular Docking Studies
  di: Aeyaz Ahmad Bhat, et al.
  Pubblicazione: (2025)
• Concentration‐QTc Modeling of the DPP‐4 Inhibitor HSK7653 in a First‐in‐Human Study of Chinese Healthy Volunteers
  di: Xiaoxu Wang, et al.
  Pubblicazione: (2024)
• SEP‐363856 exerts neuroprotection through the PI3K/AKT/GSK‐3β signaling pathway in a dual‐hit neurodevelopmental model of schizophrenia‐like mice
  di: Mengdie Li, et al.
  Pubblicazione: (2024)
• Significados e sentidos atribuídos ao Centro de Atenção Psicossocial Álcool e outras Drogas (CAPS AD) por seus usuários: um estudo de caso
  di: Clarissa de Barros Lacerda
  Pubblicazione: (2017)